Integration will reduce the burden of master lab data configuration, lowering costs and speeding Veeva LIMS implementationPLEASANTON, Calif. and DEERFIELD, Ill., Jan. 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and Zifo today announced a product partnership to help biopharmas modernize quality control (QC) operations. By bringing together Veeva LIMS with Zifo's data integration and management platform, qcKen, companies can import data directly from any source document or other LIMS into Veeva LIMS. ...

Zacks Rank and Stock Performance - The Zacks Rank system has a strong track record, with 1 ranked stocks delivering an average annual return of +25% since 1988 [1] - Veeva Systems is currently ranked 3 (Hold) by Zacks [1] - Over the past month, the Zacks Consensus EPS estimate has risen by 0.95% [1] Valuation Metrics - Veeva Systems is trading at a Forward P/E ratio of 33.68, which is a premium compared to the industry average of 28.07 [2] - The company's PEG ratio is 1.29, lower than the Internet - Software industry average of 2.18 [2] Industry Overview - The Internet - Software industry is part of the Computer and Technology sector and holds a Zacks Industry Rank of 29, placing it in the top 12% of all industries [3] - Research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [3] Recent Stock Performance - Veeva Systems' stock closed at $217.75, with a +0.21% daily movement, outperforming the S&P 500 (-1.54%), Dow (-1.63%), and Nasdaq (-1.63%) [5] - Over the past month, the stock has dropped by 6.53%, underperforming the Computer and Technology sector (+0.11%) and the S&P 500 (-2.2%) [6] Upcoming Earnings and Revenue Estimates - Analysts expect Veeva Systems to post earnings of $1.58 per share in the upcoming report, marking a year-over-year growth of 14.49% [7] - Revenue is expected to be $698.28 million, a 10.73% increase compared to the year-ago quarter [7] - For the entire fiscal year, earnings are predicted at $6.45 per share (+33.26% YoY) and revenue at $2.72 billion (+15.24% YoY) [8] Analyst Estimate Revisions - Recent changes to analyst estimates reflect evolving short-term business trends, with upward revisions indicating positivity towards the company's operations and profitability [9] - Research shows that estimate alterations are directly linked to near-term stock price performance [10]

Company Overview - Veeva (NYSE: VEEV) is at an inflection point with momentum in its Development Cloud, which houses its R&D Solutions [1] - The company has been rated as a "buy" due to its strong position and growth potential [1] Investment Strategy - Amrita runs a boutique family office fund focused on sustainable, growth-driven companies that maximize shareholder equity [1] - The fund's investment strategy is centered around meeting growth-oriented goals and democratizing financial literacy [1] - Amrita's newsletter, The Pragmatic Optimist, focuses on portfolio strategy, valuation, and macroeconomics [1] Professional Background - Amrita has 5 years of experience in high-growth supply-chain start-ups in San Francisco, where she led strategy [1] - She has worked with venture capital firms and start-ups, growing user acquisition businesses and maximizing returns for clients during the pandemic [1] - Her work aims to break down financial jargon and complex macroeconomic concepts into easily digestible formats [1] Disclosure - The analyst has a beneficial long position in Veeva (VEEV) through stock ownership, options, or other derivatives [2] - The article expresses the analyst's own opinions and is not compensated by any company mentioned [2]

Veeva Systems Inc. (VEEV) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid third-quarter fiscal 2025 performance and strategic deals, is expected to contribute further. Stiff competition and rising operational costs persist.This Zacks Rank #3 (Hold) company’s shares have risen 16.7% in the year-to-date period compared with 40.2% growth of the industry. The S&P 500 Composite has risen 27.7% during the said time frame.The renowned provide ...

Have you evaluated the performance of Veeva Systems' (VEEV) international operations for the quarter ending October 2024? Given the extensive global presence of this provider of cloud-based software services for the life sciences industry, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its fina ...

Revenue Growth - Total revenues for the three months ended October 31, 2024, increased to $699.207 million, up from $616.505 million in the same period in 2023[14] - Subscription services revenue for the three months ended October 31, 2024, increased to $580.850 million, up from $494.912 million in the same period in 2023[14] - Veeva's total revenues for the nine months ended October 31, 2024, were $2,025.7 million, compared to $1,733.1 million for the same period in 2023, representing a 16.9% increase[79] - Subscription services revenues for the nine months ended October 31, 2024, were $1,676.1 million, up from $1,380.1 million in the same period in 2023, a 21.4% increase[79] - Commercial Solutions revenues for the nine months ended October 31, 2024, were $811.5 million, compared to $733.9 million in 2023, a 10.6% increase[79] - R&D Solutions revenues for the nine months ended October 31, 2024, were $864.6 million, up from $646.2 million in 2023, a 33.8% increase[79] - Total revenues for the nine months ended October 31, 2024 were $2,025,733 thousand, compared to $1,733,055 thousand for the same period in 2023[108] - Total revenues for the three months ended October 31, 2024 increased by $83 million to $699.2 million, driven by a $86 million increase in subscription services revenues partially offset by a $3 million decrease in professional services and other revenues[109] - Subscription services revenues for the three months ended October 31, 2024 increased by 17% to $580.9 million, with R&D Solutions contributing $59 million and Commercial Solutions contributing $27 million[109] - Total revenues for the nine months ended October 31, 2024 increased by $293 million to $2.03 billion, driven by a $296 million increase in subscription services revenues partially offset by a $3 million decrease in professional services and other revenues[110] Net Income and Profitability - Net income for the three months ended October 31, 2024, rose to $185.808 million, compared to $135.158 million in the same period in 2023[14] - Gross profit for the three months ended October 31, 2024, was $524.818 million, compared to $448.823 million in the same period in 2023[14] - Operating income for the three months ended October 31, 2024, rose to $181.353 million, up from $128.489 million in the same period in 2023[14] - Diluted net income per share for the three months ended October 31, 2024, was $1.13, compared to $0.83 in the same period in 2023[14] - Net income for the nine months ended October 31, 2024, was $518.5 million, compared to $378.3 million for the same period in 2023[18] - Net income for the nine months ended October 31, 2024 was $518,513 thousand, compared to $378,307 thousand for the same period in 2023[108] - Operating income for the nine months ended October 31, 2024 was $503,012 thousand, compared to $294,070 thousand for the same period in 2023[108] - Income before income taxes for the three months ended October 31, 2024, increased by 42% to $242,290 thousand compared to $170,676 thousand in the same period in 2023[127] - Net income on a GAAP basis for the nine months ended October 31, 2024, was $518,513 thousand, up from $378,307 thousand in the same period in 2023[138] - Diluted net income per share on a GAAP basis for the nine months ended October 31, 2024, was $3.15, compared to $2.32 in the same period in 2023[138] Assets and Liabilities - Total assets as of October 31, 2024, grew to $6.452853 billion, up from $5.910920 billion as of January 31, 2024[13] - Total current assets as of October 31, 2024, increased to $5.447160 billion, up from $5.003211 billion as of January 31, 2024[13] - Total liabilities as of October 31, 2024, decreased to $951.450 million, down from $1.266096 billion as of January 31, 2024[13] - Stockholders' equity as of October 31, 2024, increased to $5.501403 billion, up from $4.644824 billion as of January 31, 2024[13] - Total stockholders' equity increased to $5.5 billion as of October 31, 2024, up from $4.6 billion at the beginning of the period[16] - Accumulated other comprehensive loss decreased to $6.5 million as of October 31, 2024, from $10.6 million at the beginning of the period[16] - Retained earnings increased to $3.3 billion as of October 31, 2024, up from $2.7 billion at the beginning of the period[16] - Total additional paid-in capital increased to $2.2 billion as of October 31, 2024, up from $1.9 billion at the beginning of the period[16] - Veeva's short-term investments as of October 31, 2024, totaled $4,018.475 million, with corporate notes and bonds making up the largest portion at $2,220.879 million[27] - The company's deferred costs were $23 million as of October 31, 2024, with amortization expenses of $4 million for the three months ended October 31, 2024[30] - Veeva's property and equipment, net, amounted to $55.695 million as of October 31, 2024, with land improvements and building improvements contributing $22.392 million[31] - Goodwill remained unchanged at $440 million as of both October 31, 2024, and January 31, 2024[33] - Intangible assets as of October 31, 2024, totaled $177.042 million, with a net value of $48.527 million after accumulated amortization of $128.515 million[34] - Estimated future amortization expense for intangible assets from 2025 to 2029 and thereafter totals $48.527 million[35] - Accrued expenses as of October 31, 2024, amounted to $34.634 million for compensation and benefits, and $30.906 million for other current liabilities[36] - Financial assets measured at fair value as of October 31, 2024, totaled $4.298 billion, with $275.389 million in Level 1 and $4.022 billion in Level 2[41] Cash Flow and Investments - Cash flows from operating activities for the nine months ended October 31, 2024, were $1.02 billion, up from $853.6 million in 2023[18] - Total cash, cash equivalents, and restricted cash at the end of the period were $1.05 billion, compared to $746.9 million at the end of the same period in 2023[18] - Net cash used in investing activities for the nine months ended October 31, 2024, was $684.4 million, compared to $989.6 million in 2023[18] - Proceeds from the exercise of common stock options for the nine months ended October 31, 2024, were $65.1 million, compared to $52.2 million in 2023[18] - Net cash provided by operating activities on a GAAP basis for the nine months ended October 31, 2024, was $1,020,507 thousand, compared to $853,570 thousand in the same period in 2023[138] - Cash, cash equivalents, and short-term investments totaled $5.1 billion as of October 31, 2024, with $62 million held outside the United States[139] - Net change in cash and cash equivalents for the nine months ended October 31, 2024, was $340,019 thousand, compared to a net decrease of $142,755 thousand in the same period in 2023[139] - Operating cash inflows primarily from subscription services and professional services, with the first quarter being seasonally strongest due to annual subscription billings[145] - Net cash provided by operating activities increased by $167 million to $1,021 million for the nine months ended October 31, 2024, driven by increased sales and cash collections[146] - Cash flows from operating activities expected to be substantially less in the fourth quarter of fiscal year 2025 due to tax payments related to the Tax Cuts and Jobs Act of 2017[147] - Net cash used in investing activities decreased by $305 million to $684 million for the nine months ended October 31, 2024, due to increased proceeds from maturities and sales of short-term investments[149] - Net cash provided by financing activities increased by $11 million to $5 million for the nine months ended October 31, 2024, primarily due to increased proceeds from employee stock option exercises[150][151] - Cash, cash equivalents, and short-term investments totaled $5.1 billion as of October 31, 2024, held primarily in demand deposit accounts, money market funds, and U.S. treasury securities[157] - An immediate 100-basis points increase in interest rates would result in a $58 million market value reduction in the investment portfolio as of October 31, 2024[159] Expenses and Costs - Research and development expenses for the nine months ended October 31, 2024 were $511,551 thousand, compared to $465,466 thousand for the same period in 2023[108] - Sales and marketing expenses for the nine months ended October 31, 2024 were $297,524 thousand, compared to $282,269 thousand for the same period in 2023[108] - General and administrative expenses for the nine months ended October 31, 2024 were $195,001 thousand, compared to $187,887 thousand for the same period in 2023[108] - Cost of subscription services revenues for the nine months ended October 31, 2024 were $239,577 thousand, compared to $213,179 thousand for the same period in 2023[108] - Cost of professional services and other revenues for the nine months ended October 31, 2024 were $279,068 thousand, compared to $290,184 thousand for the same period in 2023[108] - Total stock-based compensation for the nine months ended October 31, 2024 was $322,146 thousand, compared to $294,840 thousand for the same period in 2023[108] - Research and development expenses for the three months ended October 31, 2024 increased by $11 million to $172.4 million, primarily due to an increase in employee compensation-related costs[116] - Sales and marketing expenses for the nine months ended October 31, 2024 increased by $15 million to $297.5 million, primarily due to an increase in employee compensation-related costs[120] - General and administrative expenses for the three months ended October 31, 2024 increased by $10 million to $72.4 million, primarily due to an increase in employee compensation-related costs[122] - Cost of subscription services for the three months ended October 31, 2024 increased by $8 million to $82.6 million, primarily due to an increase in computing infrastructure costs[113] - The company expects cost of subscription services to increase in the near term due to increased usage of subscription services[114] - Stock-based compensation expense for the nine months ended October 31, 2024, was $322,146 thousand, up from $294,840 thousand in the same period in 2023[138] - Amortization of purchased intangibles for the nine months ended October 31, 2024, was $14,490 thousand, slightly down from $14,558 thousand in the same period in 2023[138] Geographic Revenue Distribution - North America accounted for $1,192.0 million of total revenues for the nine months ended October 31, 2024, representing 58.8% of total revenues[83] - Europe contributed $586.9 million to total revenues for the nine months ended October 31, 2024, accounting for 29.0% of total revenues[83] - Asia Pacific revenues for the nine months ended October 31, 2024, were $196.0 million, making up 9.7% of total revenues[83] - Middle East, Africa, and Latin America revenues for the nine months ended October 31, 2024, were $50.8 million, representing 2.5% of total revenues[83] - Geographic mix of subscription services revenues for the three months ended October 31, 2024 was 59% from North America, 28% from Europe, and 13% from other locations, primarily Asia Pacific[109] - International sales accounted for 41% of total revenues in fiscal year 2024, with expansion efforts facing challenges such as localization, data privacy laws, and longer sales cycles[184] - Approximately 2% of total revenue is attributable to China, with potential negative impact on CRM business due to data localization requirements[203] Risks and Challenges - Legal proceedings involving non-compete agreements with Medidata, IQVIA, and Sparta Systems, with trial set for June 16, 2025[168] - Risks include potential security breaches, competitive markets, reliance on key customers, and macroeconomic factors such as inflation and geopolitical conflicts[171] - Security breaches or unauthorized access to customer data could lead to significant liabilities and reputational damage, potentially causing customers to reduce or stop using the company's solutions[174] - The company processes sensitive data, including health and non-health data for U.S. patients, and faces elevated risks of cyber-attacks due to geopolitical tensions like the Russia-Ukraine conflict and Israel-Hamas conflict[174] - The company's top 10 customers accounted for 28%, 29%, and 31% of total revenues in fiscal years 2024, 2023, and 2022, respectively, making the loss of any key customer impactful[179] - The company plans to migrate Veeva CRM customers from the Salesforce platform to its own Veeva Vault platform by September 1, 2030, which could lead to business disruptions and customer loss[181] - The company faces intense competition from providers like IQVIA, Salesforce, and Oracle, with new market entrants and evolving AI technologies increasing competitive pressures[176] - Defects or disruptions in the company's solutions could result in diminished demand, reduced revenues, and substantial liability[180] - The company's sales cycles are long and unpredictable, with new applications and markets requiring significant investment without guaranteed success[183] - The company's newer solutions, such as data and analytics offerings, face uncertainty in market adoption, which could impact revenue growth[177] - The company's reliance on third-party computing infrastructure and network providers exposes it to risks of service disruptions and performance issues[180] - The company's business could be adversely affected by changes in the regulatory environment of the life sciences industry, including potential limitations on direct-to-consumer advertising and drug pricing reforms[197] - Consolidation within the life sciences industry could lead to reductions in user subscriptions or non-renewal of customer subscription orders[197] - The company's ability to attract and retain highly skilled employees is critical to its growth plan, with competition for such employees being intense[186] - The company's "Work Anywhere" policy may present long-term challenges in maintaining employee productivity and collaboration[186] - The company's business could be disrupted by catastrophic events such as natural disasters, cyber-attacks, or armed conflicts, potentially affecting its operations and results[188] - The company's future acquisitions could divert management's attention, result in additional dilution to stockholders, and disrupt operations, potentially adversely affecting operating results[189] - Reduction in funding for early-stage life sciences companies since 2022 has led to reduced sales and may continue to affect financial results[199] - Veeva CRM and Commercial Solutions sales negatively impacted by life sciences companies reducing sales representatives in favor of digitally-enabled sales channels[199] - Veeva Network and Veeva Nitro sales negatively affected by IQVIA restrictions on data uploads and usage[206] - Compliance with GDPR and UK GDPR imposes significant data protection obligations and potential penalties for noncompliance[203] - Veeva Crossix products may see reduced demand due to modifications in response to the Washington My Health My Data Act[204] - Potential delays in solution releases due to complex validation procedures required for regulatory compliance[200] - Increased costs and resource allocation needed to comply with evolving global data privacy and cybersecurity regulations[204] - Risk of reduced demand for solutions if third-party data providers like IQVIA restrict data uploads and usage[206] - Potential negative impact on customer relationships and business due to regulatory investigations or claims related to data privacy and cybersecurity[204] - Veeva Systems relies on third-party providers like Salesforce and Amazon Web Services for computing infrastructure, with potential risks of service disruptions impacting business operations[207] - Veeva CRM is currently dependent on Salesforce's platform, but the company plans to migrate customers to Vault CRM by September 2025, with a wind-down period until September 2030[209] - Salesforce terminated certain competition restrictions in May 2023, allowing it to promote third-party products competitive with Veeva CRM, potentially impacting Veeva's market position[209] - Veeva CRM Engage Meeting application uses a critical partner tool from Zoom Video Communications, and reliance on third-party software poses risks of functionality issues or increased costs[210] - Veeva's solutions incorporate open-source software, with potential risks of unanticipated license conditions or requirements to release proprietary source code[211] - Open-source software use may lead to greater risks due to lack of warranties or controls, potentially reducing the value of Veeva's solutions[212] - Salesforce and Amazon Web Services have experienced significant service outages in the past, which could adversely affect Veeva's customer experience[207] - Rapid business expansion or increased customer demand could strain Veeva's systems, potentially leading to service failures or reduced service levels[207] - Veeva's agreements with third-party computing infrastructure providers may not include service level credits matching those offered to customers, increasing financial risks[207] - Salesforce and IQVIA announced a partnership to jointly market a life sciences CRM solution, creating direct competition for Veeva CRM[209]

Veeva Systems Inc. (NYSE:VEEV) Q3 2025 Earnings Conference Call December 5, 2024 5:00 PM ET Company Participants Gunnar Hansen - Director, Investor Relations Peter Gassner - Chief Executive Officer Paul Shawah - Executive Vice President, Strategy Brian Van Wagener - Chief Financial Officer Conference Call Participants Saket Kalia - Barclays Ken Wong - Oppenheimer Joe Vruwink - Baird Brian Peterson - Raymond James Ryan MacDonald - Needham and Company Anne Samuel - J.P. Morgan Dave Windley - Jefferies Gabriel ...

For the quarter ended October 2024, Veeva Systems (VEEV) reported revenue of $699.21 million, up 13.4% over the same period last year. EPS came in at $1.75, compared to $1.34 in the year-ago quarter.The reported revenue represents a surprise of +2.20% over the Zacks Consensus Estimate of $684.18 million. With the consensus EPS estimate being $1.58, the EPS surprise was +10.76%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Str ...

Veeva Systems (VEEV) came out with quarterly earnings of $1.75 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.76%. A quarter ago, it was expected that this provider of cloud-based software services for the life sciences industry would post earnings of $1.53 per share when it actually produced earnings of $1.62, delivering ...

W Q3'25 Quarterly Results December 5, 2024 Safe Harbor and Other Information This presentation and associated commentary contain forward-looking statements regarding Veeva's expected future performance and, in particular, includes guidance, provided as of December 5, 2024, about Veeva's expected future financial results. Estimating guidance accurately for future periods is difficult. It involves assumptions and internal estimates that may prove to be incorrect and is based on plans that may change. Hence, t ...